Skip to main content

DA32 Life Science Tech Acquisition Corp. (DALS)

NASDAQ: DALS · IEX Real-Time Price · USD
9.70 -0.14 (-1.42%)
Sep 21, 2021 9:49 AM EDT - Market open
Market Cap248.81M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out25.65M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close9.84
Day's Range9.70 - 9.70
52-Week Range9.70 - 10.19
Price Targetn/a
Est. Earnings Daten/a

About DALS

DA32 Life Science Tech Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. In coming together as co-sponsors of DA32, Deerfield Management, ARCH Venture Partners and Section 32 aim to leverage their complementary capabilities and networks in order to acquire, merge with and grow a promising life science technology opportunity. We intend to focus our search for business combin...

IndustryShell Companies
IPO DateJul 28, 2021
CEOSteve Kafka
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolDALS
Full Company Profile


DA32 Life Science Tech Acquisition Corp., Sponsored by Deerfield, Arch Venture Partners and Section 32, Announces Pri...

NEW YORK--(BUSINESS WIRE)--DA32 Life Science Tech Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 20,000,000 shares of Class A common stock at a price of ...

1 month ago - Business Wire

DA32 Life Science Tech Acquisition IPO Registration Document (S-1)

DA32 Life Science Tech Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC